Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection

被引:324
|
作者
Planche, Timothy D. [1 ,2 ]
Davies, Kerrie A. [3 ,4 ]
Coen, Pietro G. [7 ]
Finney, John M. [5 ,6 ]
Monahan, Irene M. [1 ,2 ]
Morris, Kirsti A. [3 ,4 ]
O'Connor, Lily [5 ,6 ]
Oakley, Sarah J. [5 ,6 ]
Pope, Cassie F. [1 ,2 ]
Wren, Mike W. [7 ,8 ]
Shetty, Nandini P. [7 ,8 ]
Crook, Derrick W. [5 ,6 ]
Wilcox, Mark H. [3 ,4 ]
机构
[1] Univ London, Ctr Infect & Immun, Div Clin Med, London, England
[2] St Georges Healthcare NHSTrust, Dept Med Microbiol, London, England
[3] Leeds Teaching Hosp NHSTrust, Dept Microbiol, Leeds LS1 3EX, W Yorkshire, England
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Oxford Univ Hosp NHSTrust, Oxford, England
[6] Oxford Univ Hosp NHSTrust, NIHR OxBRC Infect Theme, Oxford, England
[7] Univ Coll London Hosp NHS Fdn Trust, London, England
[8] Hlth Protect Agcy, Dept Clin Microbiol & Virol, London, England
来源
LANCET INFECTIOUS DISEASES | 2013年 / 13卷 / 11期
关键词
GLUTAMATE-DEHYDROGENASE; LABORATORY DIAGNOSIS; TOXIN; DIARRHEA; DISEASE; ALGORITHM; CULTURE; GUIDELINES; STRAIN; IMPACT;
D O I
10.1016/S1473-3099(13)70200-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Diagnosis of Clostridium difficile infection is controversial because of many laboratory methods, compounded by two reference methods. Cytotoxigenic culture detects toxigenic C difficile and gives a positive result more frequently (eg, because of colonisation, which means that individuals can have the bacterium but no free toxin) than does the cytotoxin assay, which detects preformed toxin in faeces. We aimed to validate the reference methods according to clinical outcomes and to derive an optimum laboratory diagnostic algorithm for C difficile infection. Methods In this prospective, multicentre study, we did cytotoxigenic culture and cytotoxin assays on 12 420 faecal samples in four UK laboratories. We also performed tests that represent the three main targets for C difficile detection: bacterium (glutamate dehydrogenase), toxins, or toxin genes. We used routine blood test results, length of hospital stay, and 30-day mortality to clinically validate the reference methods. Data were categorised by reference method result: group 1, cytotoxin assay positive; group 2, cytotoxigenic culture positive and cytotoxin assay negative; and group 3, both reference methods negative. Findings Clinical and reference assay data were available for 6522 inpatient episodes. On univariate analysis, mortality was significantly higher in group 1 than in group 2 (72/435 [16.6%] vs 20/207 [9.7%], p=0.044) and in group 3 (503/5880 [8.6%], p<0.001), but not in group 2 compared with group 3 (p=0.4). A multivariate analysis accounting for potential confounders confirmed the mortality differences between groups 1 and 3 (OR 1.61, 95% CI 1.12-2.31). Multistage algorithms performed better than did standalone assays. Interpretation We noted no increase in mortality when toxigenic C difficile alone was present. Toxin (cytotoxin assay) positivity correlated with clinical outcome, and so this reference method best defines true cases of C difficile infection. A new diagnostic category of potential C difficile excretor (cytotoxigenic culture positive but cytotoxin assay negative) could be used to characterise patients with diarrhoea that is probably not due to C difficile infection, but who can cause cross-infection.
引用
下载
收藏
页码:936 / 945
页数:10
相关论文
共 50 条
  • [31] Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013
    Davies, K. A.
    Ashwin, H.
    Longshaw, C. M.
    Burns, D. A.
    Davis, G. L.
    Wilcox, M. H.
    EUROSURVEILLANCE, 2016, 21 (29) : 37 - 47
  • [32] Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID)
    K. Davies
    G. Davis
    F. Barbut
    C. Eckert
    N. Petrosillo
    M. H. Wilcox
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 1949 - 1956
  • [33] Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID)
    Davies, K.
    Davis, G.
    Barbut, F.
    Eckert, C.
    Petrosillo, N.
    Wilcox, M. H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (12) : 1949 - 1956
  • [34] A Prospective Study of Risk Factors and Historical Trends in Metronidazole Failure for Clostridium difficile Infection
    Hu, Mary Y.
    Maroo, Seema
    Kyne, Lorraine
    Cloud, Jeffrey
    Tummala, Sanjeev
    Katchar, Kianoosh
    Dreisbach, Valley
    Noddin, Laura
    Kelly, Ciaran P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (12) : 1354 - 1360
  • [35] Clostridium difficile infection in a French university hospital Eight years of prospective surveillance study
    Khanafer, Nagham
    Oltra, Luc
    Hulin, Monique
    Dauwalder, Olivier
    Vandenesch, Francois
    Vanhems, Philippe
    MEDICINE, 2016, 95 (23)
  • [36] Toxin B PCR cycle threshold as a predictor of poor outcome of Clostridium difficile infection: a derivation and validation cohort study
    Reigadas, E.
    Alcala, L.
    Valerio, M.
    Marin, M.
    Martin, A.
    Bouza, E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (05) : 1380 - 1385
  • [37] Prospective study of chemotherapy-induced clostridium difficile infection in lung cancer patients
    Toi, Yukihiro
    Sugawara, Shunichi
    Kobayashi, Takao
    Kawashima, Yousuke
    Koizumi, Tatsuhiko
    Okazaki, Keito
    Takahara, Masatoshi
    Kuda, Tomoya
    Tanaka, Akiko
    Ishimoto, Osamu
    Honda, Yoshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes
    Jamal, Wafaa
    Pauline, Eunice
    Rotimi, Vincent
    ANAEROBE, 2015, 35 : 28 - 32
  • [39] Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study
    Schwartz, Kevin L.
    Darwish, Ilyse
    Richardson, Susan E.
    Mulvey, Michael R.
    Thampi, Nisha
    BMC PEDIATRICS, 2014, 14
  • [40] Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study
    Kevin L Schwartz
    Ilyse Darwish
    Susan E Richardson
    Michael R Mulvey
    Nisha Thampi
    BMC Pediatrics, 14